PHARMACIELO LTD (PCLO.CA) Stock Price & Overview

TSX-V:PCLO • CA71716K1012

0.065 CAD
+0.01 (+18.18%)
Last: Mar 9, 2026, 07:00 PM

The current stock price of PCLO.CA is 0.065 CAD. Today PCLO.CA is up by 18.18%. In the past month the price decreased by -18.75%. In the past year, price decreased by -51.85%.

PCLO.CA Key Statistics

52-Week Range0.025 - 0.165
Current PCLO.CA stock price positioned within its 52-week range.
1-Month Range0.045 - 0.08
Current PCLO.CA stock price positioned within its 1-month range.
Market Cap
12.213M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.04
Dividend Yield
N/A

PCLO.CA Stock Performance

Today
+18.18%
1 Week
+30.00%
1 Month
-18.75%
3 Months
+8.33%
Longer-term
6 Months -23.53%
1 Year -51.85%
2 Years -65.79%
3 Years -83.33%
5 Years -89.68%
10 Years N/A

PCLO.CA Stock Chart

PHARMACIELO LTD / PCLO Daily stock chart

PCLO.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to PCLO.CA. When comparing the yearly performance of all stocks, PCLO.CA is a bad performer in the overall market: 92.89% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
PCLO.CA Full Technical Analysis Report

PCLO.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PCLO.CA. Both the profitability and financial health of PCLO.CA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PCLO.CA Full Fundamental Analysis Report

PCLO.CA Earnings

Next Earnings DateN/A
Last Earnings DateFeb 27, 2026
PeriodQ2 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
PCLO.CA Earnings History

PCLO.CA Forecast & Estimates


Analysts
Analysts80
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
PCLO.CA Forecast & Estimates

PCLO.CA Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

PCLO.CA Financial Highlights

Over the last trailing twelve months PCLO.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 57.3% compared to the year before.


Income Statements
Revenue(TTM)2.83M
Net Income(TTM)-6.42M
Industry RankSector Rank
PM (TTM) N/A
ROA -74.31%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%52.56%
Sales Q2Q%-33.1%
EPS 1Y (TTM)57.3%
Revenue 1Y (TTM)8.8%
PCLO.CA financials

PCLO.CA Ownership

Ownership
Inst Owners0.18%
Shares187.89M
Float171.77M
Ins Owners9.07%
Short Float %N/A
Short RatioN/A
PCLO.CA Ownership

PCLO.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BHC BAUSCH HEALTH COS INC1.232.687B
CRON CRONOS GROUP INC39.131.3B
TLRY TILRAY BRANDS INC N/A1.162B
DHT-UN DRI HEALTHCARE TRUST7.29918.667M
DHT-U DRI HEALTHCARE TRUST5.1642.517M
GUD KNIGHT THERAPEUTICS INC129.23612.126M
WEED CANOPY GROWTH CORP N/A590.015M
NGEN NERVGEN PHARMA CORP N/A451.829M
CPH CIPHER PHARMACEUTICALS INC18.16374.397M
TSND TERRASCEND CORP N/A345.979M
HITI HIGH TIDE INC24.27294.431M
ACB AURORA CANNABIS INC59.28271.641M
OGI ORGANIGRAM GLOBAL INC28.75264.855M

About PCLO.CA

Company Profile

PCLO logo image PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.

Company Info

IPO: 2018-01-30

PHARMACIELO LTD

82 Richmond Street East

TORONTO ONTARIO M5C 2V6 CA

CEO: David Attard

Employees: 49

PCLO Company Website

PCLO Investor Relations

Phone: 14163158741.0

PHARMACIELO LTD / PCLO.CA FAQ

What does PHARMACIELO LTD do?

PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.


Can you provide the latest stock price for PHARMACIELO LTD?

The current stock price of PCLO.CA is 0.065 CAD. The price increased by 18.18% in the last trading session.


Does PHARMACIELO LTD pay dividends?

PCLO.CA does not pay a dividend.


What is the ChartMill rating of PHARMACIELO LTD stock?

PCLO.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the GICS sector and industry of PCLO stock?

PHARMACIELO LTD (PCLO.CA) operates in the Health Care sector and the Pharmaceuticals industry.


How is the valuation of PHARMACIELO LTD (PCLO.CA) based on its PE ratio?

PHARMACIELO LTD (PCLO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).


Can you provide the market cap for PHARMACIELO LTD?

PHARMACIELO LTD (PCLO.CA) has a market capitalization of 12.21M CAD. This makes PCLO.CA a Nano Cap stock.